Position in RPRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,469,706
+$78,001 QoQ
Shares Held
26,212
-9.7% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#290
of 641 holders
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Investment Management Corp of Ontario holds $37,554,611 across 7 Biotechnology names. RPRX ranks #6 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
46,155 | $13,894,039 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
16,215 | $8,054,476 | |
| 3 | INCY |
Incyte Corp
|
53,029 | $6,011,367 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
7,642 | $4,765,092 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
10,300 | $1,928,984 | |
| 6 | RPRX |
Royalty Pharma plc
This page
|
26,212 | $1,469,706 | |
| 7 | INSM |
INSMED Inc
|
13,421 | $1,430,947 |
All Filings in RPRX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,469,706 | 26,212 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,391,705 | 29,012 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,070,791 | 27,712 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $629,959 | 17,856 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $325,458 | 9,033 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $331,005 | 10,633 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $271,247 | 10,633 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $360,216 | 12,733 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $227,652 | 8,633 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $250,927 | 8,933 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||